Billy Boyle FREng

Co-founder and Director, Owlstone Medical

Billy Boyle is a serial inventor, entrepreneur and a RAEng Silver Medallist. At Cambridge he co-founded Owlstone Nanotech marketing a programmable microchip sensor with applications ranging from toxic gas detection to disease diagnostics and deployed globally in the defence, oil, food, water and health sectors. Owlstone has raised over $38M with more than $32M in military contracts and was a 2008 MacRobert Award finalist.

In 2016 he led the spin out of Owlstone Medical whose non-invasive breathalyser for disease won the 2018 MacRobert Award. As CEO he leads over 170 researchers, has raised over $80M and his products are deployed in over 150 clinical sites globally.